Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

OnlinePoker

(6,149 posts)
Fri Jun 27, 2025, 01:22 PM Jun 2025

Novo Nordisk is losing Canadian patent protection on a blockbuster drug (Ozempic) after not paying a small fee

The pharma giant will lose its patent protection on semaglutide, which is sold as Ozempic and Wegovy, in Canada after not paying a nominal maintenance fee years before it became a blockbuster drug for fighting diabetes and obesity, Science reported. Novo Nordisk generates billions of dollars in revenue from the drug in Canada, but patent protection is due to end next year.

Years before semaglutide became a blockbuster drug for Novo Nordisk, the Danish pharma giant had the chance to maintain its patent in Canada but didn’t pay a small fee to do so, according to a recent report in Science.

The drug, which is sold as Ozempic and Wegovy, has made so much money for Novo Nordisk after exploding in popularity in the past few years that it has even impacted Denmark’s currency and interest rates.

To keep the semaglutide patent in Canada, the company had to pay an annual fee of just 250 Canadian dollars (~$185 USD). While it paid that amount in 2018, Science reported that it didn’t the following year.

The Canadian government offered Novo Nordisk another chance to keep its patent, this time with an additional charge that brought the total to 450 Canadian dollars ($331 USD).

https://fortune.com/2025/06/17/novo-nordisk-ozempic-wegovy-semaglutide-canada-patent-protection-fee/

-------------------------------
Sounds like someone's getting fired.

3 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Novo Nordisk is losing Canadian patent protection on a blockbuster drug (Ozempic) after not paying a small fee (Original Post) OnlinePoker Jun 2025 OP
This message was self-deleted by its author PeaceWave Jun 2025 #1
Sadly, no. Jirel Jun 2025 #2
LOL! That is AWESOME Maru Kitteh Jun 2025 #3

Response to OnlinePoker (Original post)

Jirel

(2,384 posts)
2. Sadly, no.
Fri Jun 27, 2025, 01:56 PM
Jun 2025

It’s an injectable. While people living on the border could, they can’t send this drug, which MUST be kept cold, through customs for normal shipping. Americans get custom compounded Semaglutide as a “generic” from pharmacies across the US that are relatively close by. Usually couriers drop off the packs, well packed with ice, at customers’ homes.

Maru Kitteh

(32,010 posts)
3. LOL! That is AWESOME
Fri Jun 27, 2025, 01:58 PM
Jun 2025



This will be great news for so many people. I am grateful to have no need of the drug myself at this time, but I have seen GLP-1s change lives and health for many people. You shouldn’t need perfect insurance or an excess of disposable income to obtain it.



Kick in to the DU tip jar?

This week we're running a special pop-up mini fund drive. From Monday through Friday we're going ad-free for all registered members, and we're asking you to kick in to the DU tip jar to support the site and keep us financially healthy.

As a bonus, making a contribution will allow you to leave kudos for another DU member, and at the end of the week we'll recognize the DUers who you think make this community great.

Tell me more...

Latest Discussions»General Discussion»Novo Nordisk is losing Ca...